Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

5 clinical studies listed.

Filters:

Non-small Cell Lung Cancer Stage I

Tundra lists 5 Non-small Cell Lung Cancer Stage I clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ACTIVE NOT RECRUITING

NCT04716946

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

The purpose of this study is to find out whether treatment with the study drug durvalumab combined with a type of radiation therapy called stereotactic body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung cancer (NSCLC) than SBRT alone.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-04

4 states

NSCLC
Non-small Cell Lung Cancer
Lung Cancer
+5
RECRUITING

NCT07323732

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

The purpose of this study to find out whether giving BIO 300 in combination with thoracic radiation therapy is effective in preventing pneumonitis in people with non-small cell lung cancer (NSCLC) and interstitial lung disease (ILD).

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-03

2 states

NSCLC
NSCLC, Stage I
NSCLC Stage II
+5
RECRUITING

NCT04585477

Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)

In this study circulating tumor DNA (ctDNA) blood testing is used to detect the residual blood cancer. If residual cancer using this blood test is detected there may be at higher risk of having the cancer return. The study is going to test whether or not the number of circulating cancer cells detected in the blood can be reduced by administration durvalumab after the standard treatment if you are tested positive for the residual cancer.

Gender: All

Ages: 18 Years - Any

Updated: 2026-02-10

1 state

Non-small Cell Lung Cancer
Non-small Cell Lung Cancer Stage I
Non-small Cell Lung Cancer Stage II
+1
RECRUITING

NCT02622581

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

Open, non-interventional, prospective, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCLC in Germany

Gender: All

Ages: 18 Years - Any

Updated: 2025-02-18

Metastatic Non-small Cell Lung Cancer (NSCLC)
Non-small Cell Lung Cancer Metastatic
Non-small Cell Lung Cancer Stage II
+3
RECRUITING

NCT05453721

Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane(IMPLANE-0529)

This study is a multi-center, prospective, randomized controlled clinical trial. The purpose is to compare the difference of indocyanine green fluorescence imaging method and modified inflation-deflation method in identifying intersegmental plane in segmentectomy, and provide high-level evidence for the selection of intersegmental plane identification method in early NSCLC segmental resection.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2023-09-13

1 state

Segmentectomy
Non-small Cell Lung Cancer Stage I